Analyst Ratings for BioMed Realty (BMR)
BMR Rating Summary
BMR Price Target Summary
- Highest: $24.00 (Jefferies)
- Lowest: $19.00 (BMO Capital)
- Average: $21.42
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$21.42 (-5.4%)
Avg. $ Target:
$21.42 (-5.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/13/2013 | Stifel Nicolaus | Upgrade | Buy (Hold) |
N/A (N/A) |
22.49 | 22.65 | 0.71% | Details |
| 2/14/2013 | KeyBanc | Upgrade | Buy (Hold) |
24.00 (N/A) |
20.97 | 22.65 | 8.01% | Details |
| 7/10/2012 | Cantor Fitzgerald | Upgrade | Buy (Hold) |
20.50 (N/A) |
18.76 | 22.65 | 20.74% | Details |
| 1/10/2012 | Raymond James | Downgrade | Outperform (N/A) |
21.00 (N/A) |
18.05 | 22.65 | 25.48% | Details |
| 1/9/2012 | Morgan Stanley | Downgrade | Equalweight (N/A) |
20.00 (N/A) |
18.14 | 22.65 | 24.86% | Details |
| 1/3/2012 | BMO Capital | Downgrade | Market Perform (N/A) |
19.00 (N/A) |
18.08 | 22.65 | 25.28% | Details |
| 7/14/2011 | Jefferies » Updated 2/8/2013 |
Upgrade | Buy (N/A) |
24.00 (23.00) |
19.51 | 22.65 | 16.09% | Details |
| 7/11/2011 | Wells Fargo | Downgrade | Market Perform (N/A) |
N/A (N/A) |
20.19 | 22.65 | 12.18% | Details |
| 2/17/2011 | FBR Capital » Updated 5/19/2011 |
Upgrade | Outperform (N/A) |
N/A (N/A) |
17.50 | 22.65 | 29.43% | Details |
| 10/20/2010 | Cowen | New Coverage | Neutral (N/A) |
N/A (N/A) |
18.59 | 22.65 | 21.84% | Details |
